CN1599750A - 细胞毒蛋白及该细胞毒蛋白的利用 - Google Patents
细胞毒蛋白及该细胞毒蛋白的利用 Download PDFInfo
- Publication number
- CN1599750A CN1599750A CNA02824401XA CN02824401A CN1599750A CN 1599750 A CN1599750 A CN 1599750A CN A02824401X A CNA02824401X A CN A02824401XA CN 02824401 A CN02824401 A CN 02824401A CN 1599750 A CN1599750 A CN 1599750A
- Authority
- CN
- China
- Prior art keywords
- protein
- cell
- antibody
- cytotoxic
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (18)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP371210/2001 | 2001-12-05 | ||
JP2001371210 | 2001-12-05 | ||
PCT/JP2002/012752 WO2003048199A1 (en) | 2001-12-05 | 2002-12-05 | Cytotoxic protein and utilization thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1599750A true CN1599750A (zh) | 2005-03-23 |
CN1599750B CN1599750B (zh) | 2010-05-12 |
Family
ID=19180288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN02824401XA Expired - Fee Related CN1599750B (zh) | 2001-12-05 | 2002-12-05 | 细胞毒蛋白及该细胞毒蛋白的利用 |
Country Status (25)
Country | Link |
---|---|
US (3) | US7385035B2 (zh) |
EP (1) | EP1462457B1 (zh) |
JP (1) | JP4776166B2 (zh) |
KR (1) | KR100628917B1 (zh) |
CN (1) | CN1599750B (zh) |
AT (1) | ATE393164T1 (zh) |
AU (1) | AU2002354096B2 (zh) |
BR (1) | BR0215114A (zh) |
CA (1) | CA2469154C (zh) |
CO (1) | CO5590932A2 (zh) |
DE (1) | DE60226277T2 (zh) |
ES (1) | ES2305323T3 (zh) |
HR (1) | HRP20040442A2 (zh) |
IL (1) | IL162320A0 (zh) |
IS (1) | IS7270A (zh) |
MA (1) | MA27504A1 (zh) |
MX (1) | MXPA04005459A (zh) |
NO (1) | NO20042130L (zh) |
NZ (1) | NZ533797A (zh) |
PL (1) | PL370704A1 (zh) |
RS (1) | RS49804A (zh) |
RU (1) | RU2004117155A (zh) |
TW (1) | TW200303919A (zh) |
WO (1) | WO2003048199A1 (zh) |
ZA (1) | ZA200404209B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113567671A (zh) * | 2020-04-29 | 2021-10-29 | 南京农业大学 | 猪血管紧张素转化酶2(ace2)多克隆抗体的制备 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004357586A (ja) * | 2003-06-04 | 2004-12-24 | Hiroyuki Ono | 細胞障害タンパク質m毒素の発現方法 |
WO2007072576A1 (ja) * | 2005-12-21 | 2007-06-28 | Fourier Inc. | ヘリコバクターピロリ由来m毒素大量発現株の製造方法 |
US8151835B2 (en) * | 2006-08-23 | 2012-04-10 | Fht, Inc. | Automated drug delivery bag filling system |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0218158A3 (en) | 1985-09-30 | 1988-12-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Human monoclonal antibody, B-cell line for producing this antibody and method for preparing this B-cell line and antibody. |
EP0232871A3 (en) | 1986-02-07 | 1989-03-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Human monoclonal antibody, hybridoma producing the same and its use |
JPH0798000B2 (ja) | 1987-05-23 | 1995-10-25 | 萩原 義秀 | ガン関連抗原特異的ヒト免疫グロブリン |
US5366865A (en) | 1989-04-06 | 1994-11-22 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-platelet monoclonal antibody |
US6787153B1 (en) | 1991-06-28 | 2004-09-07 | Mitsubishi Chemical Corporation | Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
US6004555A (en) | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
US5660827A (en) | 1992-03-05 | 1997-08-26 | Board Of Regents, The University Of Texas System | Antibodies that bind to endoglin |
US5877289A (en) | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US6093399A (en) | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
JP2000501621A (ja) * | 1996-03-29 | 2000-02-15 | アストラ・アクテイエボラグ | ヘリコバクターピロリに関係した核酸及びアミノ酸配列並びにそれらのワクチン組成物 |
US6417337B1 (en) | 1996-10-31 | 2002-07-09 | The Dow Chemical Company | High affinity humanized anti-CEA monoclonal antibodies |
US6348581B1 (en) | 1996-10-31 | 2002-02-19 | The Dow Chemical Company | High affinity humanized anti-TAG-72 monoclonalantibodies |
PT1021171E (pt) * | 1997-10-09 | 2003-10-31 | Dexcel Pharma Technologies Ltd | Sistema de administracao de farmacos no tracto gastrointestinal de libertacao total prolongada |
JP2000063280A (ja) * | 1998-06-11 | 2000-02-29 | Takeda Chem Ind Ltd | 抗ヘリコバクタ―・ピロリ活性胃腸薬 |
DE69941031D1 (de) | 1998-11-12 | 2009-08-06 | Novolytics Inc | Zusammensetzungen und verfahren zur erzeugung von gefässeokklusion |
WO2001070955A2 (en) * | 2000-03-21 | 2001-09-27 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
-
2002
- 2002-12-04 TW TW091135199A patent/TW200303919A/zh unknown
- 2002-12-05 RS YU49804A patent/RS49804A/sr unknown
- 2002-12-05 KR KR1020047008649A patent/KR100628917B1/ko not_active IP Right Cessation
- 2002-12-05 RU RU2004117155/13A patent/RU2004117155A/ru not_active Application Discontinuation
- 2002-12-05 ES ES02786035T patent/ES2305323T3/es not_active Expired - Lifetime
- 2002-12-05 US US10/496,384 patent/US7385035B2/en not_active Expired - Fee Related
- 2002-12-05 BR BR0215114-6A patent/BR0215114A/pt not_active IP Right Cessation
- 2002-12-05 IL IL16232002A patent/IL162320A0/xx unknown
- 2002-12-05 DE DE60226277T patent/DE60226277T2/de not_active Expired - Lifetime
- 2002-12-05 CA CA2469154A patent/CA2469154C/en not_active Expired - Fee Related
- 2002-12-05 JP JP2003549386A patent/JP4776166B2/ja not_active Expired - Fee Related
- 2002-12-05 AU AU2002354096A patent/AU2002354096B2/en not_active Ceased
- 2002-12-05 NZ NZ533797A patent/NZ533797A/en unknown
- 2002-12-05 PL PL02370704A patent/PL370704A1/xx not_active Application Discontinuation
- 2002-12-05 EP EP02786035A patent/EP1462457B1/en not_active Expired - Lifetime
- 2002-12-05 CN CN02824401XA patent/CN1599750B/zh not_active Expired - Fee Related
- 2002-12-05 WO PCT/JP2002/012752 patent/WO2003048199A1/ja active IP Right Grant
- 2002-12-05 MX MXPA04005459A patent/MXPA04005459A/es active IP Right Grant
- 2002-12-05 AT AT02786035T patent/ATE393164T1/de not_active IP Right Cessation
-
2004
- 2004-05-17 IS IS7270A patent/IS7270A/is unknown
- 2004-05-18 HR HRP20040442 patent/HRP20040442A2/hr not_active Application Discontinuation
- 2004-05-24 NO NO20042130A patent/NO20042130L/no not_active Application Discontinuation
- 2004-05-28 ZA ZA200404209A patent/ZA200404209B/en unknown
- 2004-07-01 CO CO04062951A patent/CO5590932A2/es not_active Application Discontinuation
- 2004-07-05 MA MA27761A patent/MA27504A1/fr unknown
-
2008
- 2008-04-21 US US12/106,775 patent/US20090208972A1/en not_active Abandoned
- 2008-04-21 US US12/106,806 patent/US20080233556A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113567671A (zh) * | 2020-04-29 | 2021-10-29 | 南京农业大学 | 猪血管紧张素转化酶2(ace2)多克隆抗体的制备 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6316195B2 (ja) | モノクローナル抗体および使用の方法 | |
CN1382259A (zh) | 检测粪便中抗酸微生物的改进方法 | |
CN103890009A (zh) | 白细胞介素-31单克隆抗体 | |
EA032084B1 (ru) | Антагонисты pcsk9 | |
JPH10503081A (ja) | Tie2/tekレセプタ細胞外ドメインに結合する免疫相互作用性分子 | |
CN103582651A (zh) | 识别人类乳突病毒(hpv)l2蛋白质的单克隆抗体及使用其的测定hpv中和抗体的效价的方法 | |
CN1993619A (zh) | 作为β细胞衰竭靶标/标志的TIMP-2 | |
CN1418225A (zh) | 人低密度脂蛋白受体的单克隆抗体及其制备和用途 | |
CN1305497A (zh) | 抗g3bp蛋白的单克隆抗体及应用 | |
CN1599750A (zh) | 细胞毒蛋白及该细胞毒蛋白的利用 | |
WO2000077045A1 (fr) | Proteine et adn de cette proteine | |
CN1844150A (zh) | 可溶性人cd28分子检测试剂盒及其应用 | |
KR20100034720A (ko) | 피에이유에프(pauf) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법 | |
JP2001231578A (ja) | Il−1ファミリーに属する蛋白質 | |
CN1352685A (zh) | 单核细胞来源的核酸和相关的组合物及方法 | |
KR102274759B1 (ko) | 황색포도알균 장독소 b에 특이적인 항체 및 이의 용도 | |
US20220332809A1 (en) | Monoclonal antibodies against bambi and use thereof for treating inflammatory diseases | |
CN1173735C (zh) | 抗-gp39抗体在狼疮及相关肾病的治疗和/或逆转中的应用 | |
CN1155619C (zh) | 抗-tpo单克隆抗体 | |
MX2007008559A (es) | Identificacion de fosfolipasa a2 como objetivo en el tratamiento de cancer, con enfasis especial en el cancer colorrectal y su mecanismo de accion. | |
JP3072919B2 (ja) | 単クローン性抗体及びこれを用いた診断方法 | |
JP2004141161A (ja) | ズブチリシン様プロプロテインコンベルターゼ・pace4に対するモノクローナル抗体及びその利用 | |
CN1368978A (zh) | 新蛋白质及其应用 | |
CN1103404A (zh) | 识别表皮生长因子受体的新的单克隆抗体,生产这种抗体的细胞和方法以含有这种抗体的组合物 | |
JP2001031700A (ja) | 新規抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: FOURIER CO., LTD. Free format text: FORMER OWNER: HIROYUKI ONO Effective date: 20060825 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20060825 Address after: Chiba County, Japan Applicant after: Fourier Co., Ltd. Address before: Chiba County, Japan Applicant before: Ohno Hiroyuki |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100512 Termination date: 20121205 |